Author: Rappuoli, Rino; Bottomley, Matthew J.; D’Oro, Ugo; Finco, Oretta; De Gregorio, Ennio
Title: Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design Cord-id: uyoerxvu Document date: 2016_4_4
ID: uyoerxvu
Snippet: Traditionally, vaccines have been developed by cultivating infectious agents and isolating the inactivated whole pathogen or some of its purified components. 20 years ago, reverse vaccinology enabled vaccine discovery and design based on information deriving from the sequence of microbial genomes rather than via the growth of pathogens. Today, the high throughput discovery of protective human antibodies, sequencing of the B cell repertoire, and the increasing structural characterization of prote
Document: Traditionally, vaccines have been developed by cultivating infectious agents and isolating the inactivated whole pathogen or some of its purified components. 20 years ago, reverse vaccinology enabled vaccine discovery and design based on information deriving from the sequence of microbial genomes rather than via the growth of pathogens. Today, the high throughput discovery of protective human antibodies, sequencing of the B cell repertoire, and the increasing structural characterization of protective antigens and epitopes provide the molecular and mechanistic understanding to drive the discovery of novel vaccines that were previously impossible. We are entering a “reverse vaccinology 2.0†era.
Search related documents:
Co phrase search for related documents- ab antigen and ab functionality: 1
- ab antigen and ab functionality direct screening: 1
- ab antigen and ab repertoire: 1, 2, 3
- ab antigen and ab repertoire limited slice: 1
- ab antigen and ab response: 1, 2, 3, 4
- ab antigen and ab sequence: 1
- ab antigen and ab sequence repertoire: 1
- ab antigen and ab specificity: 1, 2, 3
- ab antigen and abs identify: 1
- ab antigen and abs small subset: 1
- ab antigen and abs structural characterization: 1
- ab antigen and acute dengue infection: 1
- ab antigen and additional highly potent rsv specific nabs: 1
- ab antigen and low throughput: 1
- ab antigen and mabs isolate: 1
- ab antigen and mabs rabbit chimeric murine: 1
- ab antigen and mabs rabbit chimeric murine expression: 1
- ab antigen and mabs specific: 1
- ab antigen complex and ab functionality: 1
Co phrase search for related documents, hyperlinks ordered by date